United States

Schulman Associates IRB offers oncology-focused review board

Wednesday, June 27, 2012 03:46 PM

In response to the recent increases in oncology research conducted in North America, Schulman Associates IRB will offer a weekly board meeting of the new Schulman Oncology Board, dedicated to the review of oncology research, beginning July 23.

More... »

Medidata-sponsored study identifies up to $5B in potential trial cost savings

Wednesday, June 27, 2012 03:37 PM

The results of a new research study performed by the Center for the Study of Drug Development at Tufts University School of Medicine and sponsored by Medidata Solutions, a global provider of cloud-based clinical development solutions, found that clinical data gathered from 25% of the procedures administered to patients may be unnecessary—and, in the aggregate, are responsible for $3-5 billion in overall clinical trial costs annually.

More... »

Y-Prime launches Prime Publisher to streamline content review, combine data for reports

Wednesday, June 27, 2012 03:07 PM

Y-Prime Technologies, an eClinical products and consulting company of Malvern, Penn., is expanding its suite of eClinical software solutions with Prime Publisher, an easy-to-use concatenation tool that streamlines the content review process and combines multiple data forms into a single, navigable format.

More... »

Exco InTouch named ‘Microsoft Managed Partner’ within life sciences

Wednesday, June 27, 2012 02:51 PM

Exco InTouch, a provider of mobile patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, has been named a Microsoft Managed Partner.

More... »

Nextrials’s new iPad app to offer mobile access to clinical trial data and study metrics

Wednesday, June 27, 2012 02:17 PM

Nextrials, a web-based software solutions company for the clinical research industry, announced that its iPad application for Prism, its award-winning clinical trial management platform, will be available toward the end of Q3 2012.  

More... »

Roche to streamline R&D activities, close New Jersey site

Wednesday, June 27, 2012 10:46 AM

Roche has decided to consolidate activities within its research and early development division, resulting in the closure of the company’s Nutley, N.J., site. Research and development activities will be consolidated at the existing sites in Germany and Switzerland, focusing on oncology, virology, metabolism and neuroscience.

More... »

Soligenix, IDRI to develop thermostabilized biodefense vaccines

Wednesday, June 27, 2012 09:44 AM

Soligenix, a development stage biopharmaceutical company, has entered into a collaboration with the Infectious Disease Research Institute (IDRI) of Seattle, Wash., to develop select biodefense vaccines using IDRI's potent and safe synthetic adjuvants in conjunction with Soligenix's proprietary subunit proteins and thermostability platform, ThermoVax. 

More... »

Lexicon touts significant results for LX4211 phase IIb trial in T2D

Monday, June 25, 2012 03:50 PM

Lexicon Pharmaceuticals of The Woodlands, Texas, has reported that LX4211, an investigational, oral, dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2), showed substantial, dose-dependent, statistically-significant reductions in hemoglobin A1c (HbA1c) in a phase IIb trial in patients diagnosed with poorly-controlled type 2 diabetes who were concurrently treated with metformin, an established diabetes therapy.

More... »

Amgen, actress Maura Tierney launch ‘Chemotherapy: Myths or Facts’ campaign

Monday, June 25, 2012 03:30 PM

Amgen, a biotech based in Thousand Oaks, Calif., has launched Chemotherapy: Myths or Facts, an awareness campaign for cancer patients and their caregivers featuring Emmy-nominated actress and breast cancer survivor Maura Tierney.

More... »

Paragonix Technologies names Leonard A. R. Golding as CMO

Monday, June 25, 2012 11:11 AM

Paragonix Technologies, a medical device company of Cambridge, Mass., has appointed Leonard A. R. Golding, MB, BS, FRACS, FRCS(C), FACC, as chief medical officer.

More... »